A phase III parallel group comparison study of HP-3000 in patients with Parkinson's disease using L-DOPA

Next Previous
Trial Profile

A phase III parallel group comparison study of HP-3000 in patients with Parkinson's disease using L-DOPA

Recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Nov 2016

At a glance

  • Drugs Ropinirole (Primary) ; Ropinirole (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Hisamitsu Pharmaceutical

    • Most Recent Events

    • 08 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top